“If you choose to use HT to prevent chronic conditions,
it may be in your best interest to also choose to talk to
your health care provider about this”. Meno Martha

Umbrella
What may the Hormone Therapy 2022 Update for Chronic Conditions Umbrella include?

Depending on the Source (DotS) this Umbrella may include:

  • Chronic Conditions/Diseases/Illnesses
  • Hormone Replacement Therapy (HRT)
  • Hormone Therapy (HT)
  • Hormone Therapy and Cancer
  • Hormone Therapy and Dementia
  • Hormone Therapy and Heart Disease and Stroke (Cardiovascular Disease)
  • Hormone Therapy and Osteoporosis
  • Menopausal Hormone Therapy (MHT)

Date

What can it be important to be clear about with hormone therapy (HT) information?

It can be important to be clear about the date of all information including the date of HT information, because this information may have been updated.

Symptoms or Chronic Conditions

What can it also be important to be clear about with HT information?

It can also be important to be clear about whether HT information is about the use of HT for the management of menopausal symptoms such as hot flushes, night sweats and vaginal dryness; or for the prevention of chronic conditions such as cardiovascular disease, cancer and osteoporosis.

2017 Recommendations Update

When did the (United States) Preventative Services Task Force (USPSTF) update their 2017 recommendations on the use of HT in postmenopausal women for the primary prevention of chronic conditions?

The USPSTF updated their 2017 recommendations on 01 November 2022.

2022 Recommendations

What did the USPSTF’s 2022 recommendations include?

Hormone Therapy and AgingIn Hormone Therapy In Postmenopausal Persons: Primary Prevention of Chronic Conditions – Recommendation Summary, the USPSTF recommend:

“Postmenopausal persons
The USPSTF recommends against the use of combined estrogen and progestin for the primary prevention of chronic conditions in postmenopausal persons”.1

Hormone Therapy and AgingIn Hormone Therapy In Postmenopausal Persons: Primary Prevention of Chronic Conditions – Recommendation Summary, the USPSTF recommended:

“Postmenopausal persons who have had a hysterectomy
The USPSTF recommends against the use of estrogen alone for the primary prevention of chronic conditions in postmenopausal persons who have had a hysterectomy”.2

Recommendation Applies To

To whom does the USPSTF’s 2022 recommendation apply?

In Hormone Therapy In Postmenopausal Persons: Primary Prevention of Chronic Conditions – Clinician Summary: To Whom Does This Recommendation Apply the USPSTF note:

“This recommendation applies to asymptomatic, postmenopausal persons who are considering hormone therapy for the primary prevention of chronic medical conditions. It does not apply to persons who are considering hormone therapy for the management of perimenopausal symptoms, such as hot flashes or vaginal dryness. It also does not apply to persons who have had premature menopause (primary ovarian insufficiency) or surgical menopause”.3

Health Care Provider

What if I choose to use HT to prevent chronic conditions?

If you choose to use HT to prevent chronic conditions, it may be in your best interest to also choose to talk to your health care provider about this.

Health Topics A-Z

Where may I find Health Topics related to Hormone Therapy 2022 Update for Chronic Conditions?

In Health Topics A-Z you may find:

Links

Where may I find Links related to Hormone Therapy 2022 Update for Chronic Conditions?

Your Country may have Links similar to:

Sources

Where may I find the Sources quoted?

You may find the Sources quoted at:

Sources

  1. Hormone Therapy In Postmenopausal Women: Primary Prevention of Chronic Conditions – Recommendation Summary. 01 November 2022. U.S. Preventative Services Task Force https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication Accessed: 03 November 2022
  2. Hormone Therapy In Postmenopausal Women: Primary Prevention of Chronic Conditions – Recommendation Summary. 01 November 2022. U.S. Preventative Services Task Force https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication Accessed: 03 November 2022
  3. Hormone Therapy In Postmenopausal Women: Primary Prevention of Chronic Conditions – Clinician Summary: To Whom Does This Recommendation Apply. 01 November 2022. U.S. Preventative Services Task Force https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication Accessed: 03 November 2022
Topic Last Updated: 03 November 2022 – Topic Last Reviewed: 03 November 2022

Print Friendly, PDF & Email